Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden.

ABSTRACT:

Background

There are limited data on population-wide assessment of cost in Crohn's disease (CD) and ulcerative colitis (UC).

Aim

To estimate the societal cost of actively treated CD and UC in Sweden.

Methods

We identified 10 117 prevalent CD and 19 762 prevalent UC patients, aged ≥18 years on 1 January 2014 and 4028 adult incident CD cases and 8659 adult incident UC cases (2010-2013) from Swedish Patient Register. Each case was matched to five population comparators. Healthcare costs were calculated from medications, outpatient visits, hospitalisations and surgery. Cost of productivity losses was derived from disability pension and sick leave.

Results

The mean annual societal costs per working-age patient (18-64 years) with CD and UC were $22 813 (vs $7533 per

SUBMITTER: Khalili H 

PROVIDER: S-EPMC7490827 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature